CARDIOL THERAPEUTICS INC-A
CRDL · NASDAQ
Updated at 2026-10-13 15:00:17
- Today's High
- $1.24
- Today’s Low
- $1.18
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.27
- Previous Close
- $1.18
- Volume
- 1.75M
- Market Cap
- $214.77M
- P/E Ratio
- --
- EPS
- $-0.34
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- DRUG MANUFACTURERS - SPECIALTY & GENERIC
- Headquarters
- 2265 UPPER MIDDLE ROAD EAST, OAKVILLE, ON, CANADA, L6H 0G5
- Country
- CA
- Listing Date
- 2018-12-20
- Fiscal Year End
- December
- Shares Outstanding
- 115.24M
- CIK
- 0001702123
- Website
- www.cardiolrx.com
Cardiol Therapeutics Inc., a clinical-phase biotechnology company, focuses on the research and development of anti-inflammatory therapies for the treatment of cardiovascular diseases (CVD). The company is headquartered in Oakville, Canada.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$11.28M
2026-03-31
$9.7M
2025-12-31
$8.03M
2025-09-30
$10.18M
Net Income
2026-06-30
-$8.64M
2026-03-31
-$10.84M
2025-12-31
-$7.21M
2025-09-30
-$9.96M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.04
2026-03-31
$-0.05
2025-12-31
$-0.07
2025-09-30
$-0.12
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$8.91M
2026-03-31
-$10.81M
2025-12-31
-$7.18M
2025-09-30
-$9.93M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $11.28M | $9.7M | $8.03M | $10.18M |
| Net Income | -$8.64M | -$10.84M | -$7.21M | -$9.96M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.04 | $-0.05 | $-0.07 | $-0.12 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$8.91M | -$10.81M | -$7.18M | -$9.93M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.